Application Assignment Due Date Gc Ms Detection

1. Langman L. J., Kapur B. M. (2006) Toxicology: Then and now, Clin Biochem39, 498-510. [PubMed]

2. Holsapple M. P., Wallace K. B. (2008) Dose response considerations in risk assessment--an overview of recent ILSI activities, Toxicol Lett180, 85-92. [PubMed]

3. Smith M. L., Vorce S. P., Holler J. M., Shimomura E., Magluilo J., Jacobs A. J., Huestis M. A. (2007) Modern instrumental methods in forensic toxicology, J Anal Toxicol31, 237-253, 238A-239A. [PMC free article][PubMed]

4. Viette V., Hochstrasser D., Fathi M. (2012) LC-MS (/MS) in Clinical Toxicology Screening Methods, Chimia66, 339-342. [PubMed]

5. Goulle J. P., Saussereau E., Mahieu L., Guerbet M. (2014) Current role of ICP-MS in clinical toxicology and forensic toxicology: a metallic profile, Bioanalysis6, 2245-2259. [PubMed]

6. Shannon M., Cox M. N., Baum C. R. (1998) Toxicology reviews: Immunoassay in detecting drugs of abuse, Pediatr Emerg Care14, 372-375. [PubMed]

7. Holstege C. P., Borek H. A. (2012) Toxidromes, Crit Care Clin28, 479-+. [PubMed]

8. Pappas A. A., Massoll N. A., Cannon D. J. (1999) Toxicology: Past, present, and future, Ann Clin Lab Sci29, 253-262. [PubMed]

9. Ettre L. S., Sakodynskii K. I. (1993) Tswett,M.S. And the Discovery of Chromatography .2. Completion of the Development of Chromatography (1903-1910), Chromatographia35, 329-338.

10. Pippenger C. E. (1979) Therapeutic drug monitoring: an overview, Ther Drug Monit1, 3-9. [PubMed]

11. Wen B., Zhu M. S. (2015) Applications of mass spectrometry in drug metabolism: 50 years of progress, Drug Metab Rev47, 71-87. [PubMed]

12. Glish G. L., Vachet R. W. (2003) The basics of mass spectrometry in the twenty-first century, Nat Rev Drug Discov2, 140-150. [PubMed]

13. Grebe S. K. G., Singh R. J. (2011) LC-MS/MS in the Clinical Laboratory – Where to From Here?, Clin. Biochem. Rev.32, 5-31. [PMC free article][PubMed]

14. Garg U., Zhang Y. V. (2016) Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology, Methods Mol Biol1383, 1-10. [PubMed]

15. Maurer H. H., Meyer M. R. (2016) High-resolution mass spectrometry in toxicology: current status and future perspectives, Arch Toxicol90, 2161-2172. [PubMed]

16. Hart-Smith G., Blanksby S. J. (2012) Mass analysis, in Mass Spectrometry in Polymer Chemistry (eds Barner-Kowollik C., Gruendling T., Falkenhagen J., Weidner S., editors. ), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany: doi: 10.1002/9783527641826.ch1.

17. Nair H., Woo F., Hoofnagle A. N., Baird G. S. (2013) Why GCMS Remains an Invaluable Tool in a Toxicology Lab: A Novel Approach to Clinical Validation of a High Sensitive GCMS Platform for Urine Drug Screening, American journal of clinical pathology140, 431-431.

18. Ojanpera I., Kolmonen M., Pelander A. (2012) Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control, Anal Bioanal Chem403, 1203-1220. [PubMed]

19. Becker J. O., Hoofnagle A. N. (2012) Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS, Bioanalysis4, 281-290. [PMC free article][PubMed]

20. Strathmann F. G., Hoofnagle A. N. (2011) Current and future applications of mass spectrometry to the clinical laboratory, American journal of clinical pathology136, 609-616. [PubMed]

21. Jannetto P. J., Fitzerald R. L. (2016) Effective Use of Mass Spectrometry in the Clinical Laboratory, Clin Chem62, 92-98. [PubMed]

22. Adaway J. E., Keevil B. G., Owen L. J. (2015) Liquid chromatography tandem mass spectrometry in the clinical laboratory, Ann Clin Biochem52, 18-38. [PubMed]

23. Lynch K. L., Breaud A. R., Vandenberghe H., Wu A. H. B., Clarke W. (2010) Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening, Clin Chim Acta411, 1474-1481. [PMC free article][PubMed]

24. Chauhan A., Goyal M. K., Chauhan P. (2014) GC-MS Technique and its Analytical Applications in Science and Technology, J. Anal. Bioanal. Tech.5, 222.

25. Yuan C., Chen D., Wang S. H. (2015) Drug confirmation by mass spectrometry: Identification criteria and complicating factors, Clin Chim Acta438, 119-125. [PubMed]

26. Vogeser M. (2003) Liquid chromatography-tandem mass spectrometry - Application in the clinical laboratory, Clin Chem Lab Med41, 117-126. [PubMed]

27. Fernandez M. D. R., Di Fazio V., Wille S. M. R., Kummer N., Samyn N. (2014) A quantitative, selective and fast ultra-high performance liquid chromatography tandem mass spectrometry method for the simultaneous analysis of 33 basic drugs in hair (amphetamines, cocaine, opiates, opioids and metabolites), J Chromatogr B965, 7-18. [PubMed]

28. Maurer H. H. (2010) Perspectives of Liquid Chromatography Coupled to Low- and High-Resolution Mass Spectrometry for Screening, Identification, and Quantification of Drugs in Clinical and Forensic Toxicology, Ther Drug Monit32, 324-327. [PubMed]

29. Meyer M. R., Maurer H. H. (2012) Current applications of high-resolution mass spectrometry in drug metabolism studies, Anal Bioanal Chem403, 1221-1231. [PubMed]

30. Caldwell G. W., Yan Z., Tang W., Dasgupta M., Hasting B. (2009) ADME optimization and toxicity assessment in early- and late-phase drug discovery, Curr Top Med Chem9, 965-980. [PubMed]

31. Meyer M. R., Maurer H. H. (2016)

1. Gao P, Lu C, Zhang F, Sang P, Yang D, Li X, Kong H, Yin P, Tian J, Lu X, Lu A, Xu G. Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis. Analyst. 2008;133:1214–1220.[PubMed]

2. Klavins K, Drexler H, Hann S, Koellensperger G. Quantitative metabolite profiling utilizing parallel column analysis for simultaneous reversed-phase and hydrophilic interaction liquid chromatography separations combined with tandem mass spectrometry. Anal. Chem. 2014;86:4145–4150.[PubMed]

3. Arbona V, Iglesias DJ, Talon M, Gomez-Cadenas A. Plant phenotype demarcation using nontargeted LC-MS and GC-MS metabolite profiling. J. Agric. Food Chem. 2009;57:7338–7347.[PubMed]

4. Zhang J, Wei S, Liu L, Gowda GAN, Bonney P, Stewart J, Knapp DW, Raftery D. NMR-based metabolomics study of canine bladder cancer. Biochim. Biophys. Acta, Mol. Basis Dis. 2012;1822:1807–1814.[PubMed]

5. Bingol K, Bruschweiler R. Multidimensional Approaches to NMR-Based Metabolomics. Anal. Chem. 2014;86:47–57.[PMC free article][PubMed]

6. Wei X, Shi X, Koo I, Kim S, Schmidt RH, Arteel GE, Watson WH, McClain C, Zhang X. MetPP: A computational platform for comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics. Bioinformatics. 2013;29:1786–1792.[PMC free article][PubMed]

7. Castillo S, Mattila I, Miettinen J, Oresic M, Hyotylainen T. Data analysis tool for comprehensive two-dimensional gas chromatography/ time-of-flight mass spectrometry. Anal. Chem. 2011;83:3058–3067.[PubMed]

8. Hoggard JC, Synovec RE. Automated resolution of nontarget analyte signals in GC × GC-TOFMS data using parallel factor analysis. Anal. Chem. 2008;80:6677–6688.[PubMed]

9. Schmidt RH, Jokinen JD, Massey VL, Falkner KC, Shi X, Yin XM, Zhang X, Beier JI, Arteel GE. Olanzapine activates hepatic mammalian target of rapamycin: New mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs. J. Pharmacol. Exp. Ther. 2013;347:126–135.[PMC free article][PubMed]

10. Shi X, Wei X, Koo I, Schmidt RH, Yin X, Vaughn A, Kim SH, McClain CJ, Arteel GE, Zhang X, Watson WH. Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced fatty liver disease. J. Proteome Res. 2014;13:547–554.[PMC free article][PubMed]

11. Wang YW, Chen QA, Norwood DL, McCaffrey J. Recent development in the applications of comprehensive two-dimensional gas chromatograph. J. Liq. Chromatogr. Relat. Technol. 2010;33:1082–1115.

12. Panic O, Gorecki T. Comprehensive two-dimensional gas chromatography (GC×GC) in environmental analysis and monitoring. Anal. Bioanal. Chem. 2006;386:1013–1023.[PubMed]

13. Dalluge J, Beens J, Brinkman UAT. Comprehensive two-dimensional gas chromatography: a powerful and versatile analytical tool. J. Chromatogr. A. 2003;1000:69–108.[PubMed]

14. Seeley JV, Seeley SK. Multidimensional gas chromatography: Fundamental advances and new applications. Anal. Chem. 2013;85:557–578.[PubMed]

15. Bhattacharya S, Dunham AA, Cornish MA, Christian VA, Ginsburg GS, Tenenbaum JD, Nahm ML, Miranda ML, Califf RM, Dolor RJ, Newby LK. The measurement to understand reclassification of disease of Cabarrus/Kannapolis (MURDOCK) study community registry and biorepository. Am. J. Transl. Res. 2012;4:458–470.[PMC free article][PubMed]

16. Wang B, Fang A, Heim J, Bogdanov B, Pugh S, Libardoni M, Zhang X. DISCO: Distance and spectrum correlation optimization alignment for two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics. Anal. Chem. 2010;82:5069–5081.[PMC free article][PubMed]

17. Zhang J, Fang AQ, Wang B, Kim SH, Bogdanov B, Zhou ZX, McClain C, Zhang X. iMatch: A retention index tool for analysis of gas chromatography-mass spectrometry data. J. Chromatogr. A. 2011;1218:6522–6530.[PMC free article][PubMed]

18. Astrand M. Contrast normalization of oligonucleotide arrays. J. Comput. Biol. 2003;10:95–102.[PubMed]

19. Vivo-Truyols G. Bayesian approach for peak detection in twodimensional chromatography. Anal. Chem. 2012;84:2622–2630.[PubMed]

20. Wei X, Shi X, Kim S, S K, Patrick JS, Binkley J, Kong M, McClain C, Zhang X. Data dependent chromatographic peak model-based spectrum deconvolution for analysis of LC-MS data. Anal. Chem. 2014;86:2156–2165.[PMC free article][PubMed]


Leave a Reply

Your email address will not be published. Required fields are marked *